1. Home
  2. GP vs APM Comparison

GP vs APM Comparison

Compare GP & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GreenPower Motor Company Inc.

GP

GreenPower Motor Company Inc.

HOLD

Current Price

$1.22

Market Cap

6.7M

ML Signal

HOLD

Logo Aptorum Group Limited

APM

Aptorum Group Limited

HOLD

Current Price

$0.86

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GP
APM
Founded
2010
2010
Country
Canada
United Kingdom
Employees
113
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.3M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
GP
APM
Price
$1.22
$0.86
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
169.4K
283.3K
Earning Date
02-12-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.65
52 Week High
$4.00
$4.47

Technical Indicators

Market Signals
Indicator
GP
APM
Relative Strength Index (RSI) 58.20 46.90
Support Level $1.02 $0.76
Resistance Level $1.37 $0.93
Average True Range (ATR) 0.08 0.15
MACD 0.02 -0.02
Stochastic Oscillator 55.26 10.33

Price Performance

Historical Comparison
GP
APM

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Aptorum's project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA). Substantially all of the company's revenues are derived from within Hong Kong.

Share on Social Networks: